| # | Drug | Count |
|---|---|---|
| 0 | EPOPROSTENOL | 416 |
| 1 | TREPROSTINIL | 304 |
| 2 | SILDENAFIL CITRATE | 285 |
| 3 | MACITENTAN | 278 |
| 4 | TADALAFIL | 248 |
| 5 | AMBRISENTAN | 211 |
| 6 | SILDENAFIL | 199 |
| 7 | FUROSEMIDE | 106 |
| 8 | 0XYGEN | 101 |
| 9 | OXYGEN | 101 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | EPOPROSTENOL | 416 | 0.0317 |
| 1 | MACITENTAN | 278 | 0.0040 |
| 2 | SOTATERCEPT-CSRK | 24 | 0.0039 |
| 3 | RIOCIGUAT | 90 | 0.0027 |
| 4 | TADALAFIL | 248 | 0.0025 |
| 5 | SILDENAFIL POWDER, | 87 | 0.0024 |
| 6 | TREPROSTINIL | 304 | 0.0024 |
| 7 | SILDENAFIL CITRATE | 285 | 0.0022 |
| 8 | FOSCARBIDOPA/FOSLEVODOPA | 18 | 0.0020 |
| 9 | 0XYGEN | 101 | 0.0020 |
| # | Drug class | Count |
|---|---|---|
| 0 | Prostacycline Vasodilator [EPC] | 665 |
| 1 | Endothelin Receptor Antagonist [EPC] | 474 |
| 2 | Phosphodiesterase 5 Inhibitor [EPC] | 321 |
| 3 | Loop Diuretic [EPC] | 137 |
| 4 | Factor Xa Inhibitor [EPC] | 105 |
| 5 | Soluble Guanylate Cyclase Stimulator [EPC] | 90 |
| 6 | Osmotic Laxative [EPC] | 85 |
| 7 | Aldosterone Antagonist [EPC] | 68 |
| 8 | Nonsteroidal Anti-inflammatory Drug [EPC] | 66 |
| 9 | Potassium Salt [EPC] | 56 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Prostacycline Vasodilator [EPC] | 665 | 0.0048 |
| 1 | Soluble Guanylate Cyclase Stimulator [EPC] | 90 | 0.0027 |
| 2 | Phosphodiesterase 5 Inhibitor [EPC] | 321 | 0.0024 |
| 3 | Endothelin Receptor Antagonist [EPC] | 474 | 0.0024 |
| 4 | Provitamin D2 Compound [EPC] | 44 | 0.0015 |
| 5 | Prostacyclin Receptor Agonist [EPC] | 35 | 0.0013 |
| 6 | Guanylate Cyclase-C Agonist [EPC] | 2 | 0.0010 |
| 7 | Glycolipid Disialoganglioside-directed Antibody [EPC] | 1 | 0.0009 |
| 8 | Barbiturate [EPC] | 8 | 0.0007 |
| 9 | Antiseptic [EPC] | 3 | 0.0007 |